SCHEMBL30176374

SCHEMBL30176374

Cc1cc(-n2cc(C3CC4(CC(C(=O)O)C4)C3)c3cc(OCc4ccccc4)ccc32)ccc1F

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
S1PR5 Q9H228 3/20 0.42
S1PR1 P21453 2/20 0.42
CNR1 P21554 1/20 0.39
CNR2 P34972 1/20 0.39
PDE3B Q13370 1/20 0.38
PDE3A Q14432 1/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
SRD5A2 P31213 1/20 0.37
EDNRB P24530 2/20 0.36
EDNRA P25101 2/20 0.36
PRKX P51817 1/20 0.36
ACVR1 Q04771 1/20 0.36
PLA2G4A P47712 1/20 0.36
LTB4R Q15722 1/20 0.36
LTB4R2 Q9NPC1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23886923 1.00 S1PR5 (0.42) S1PR5S1PR1CNR1CNR2PDE3B
SCHEMBL30176351 0.86 CNR1 (0.40) S1PR5S1PR1CNR1CNR2MEN1
SCHEMBL30337937 0.86 CNR1 (0.40) S1PR5S1PR1CNR1CNR2MEN1
SCHEMBL23886693 0.86 CNR1 (0.40) S1PR5S1PR1CNR1CNR2MEN1
SCHEMBL30337929 0.79 CNR1 (0.40) CNR1CNR2MEN1NPC1RAB9A
SCHEMBL28995420 0.76 PLA2G4A (0.57) PLA2G4ALTB4RLTB4R2
SCHEMBL23886848 0.75 PLA2G4A (0.46) MEN1NPC1RAB9AKMT2ASRD5A2
SCHEMBL30176331 0.75 PLA2G4A (0.46) MEN1NPC1RAB9AKMT2ASRD5A2
SCHEMBL23886840 0.75 S1PR3 (0.39) S1PR5S1PR1CNR1CNR2MEN1
SCHEMBL30337657 0.75 S1PR3 (0.39) S1PR5S1PR1CNR1CNR2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4126817-A1 SUBSTITUTED 5-HYDROXYINDOLE COMPOUNDS AS MODULATORS OF ALPHA-1 ANTITRYPSIN Vertex Pharmaceuticals Incorporated (US) 2023-02-08 EP disclosed